tiprankstipranks
China SXT Pharmaceuticals Inc (DE:2RY2)
FRANKFURT:2RY2
Germany Market
2RY2
China SXT Pharmaceuticals
RESEARCH TOOLSreports

China SXT Pharmaceuticals (2RY2) Income Statement

0 Followers

China SXT Pharmaceuticals Income Statement

Last quarter (Q4 2026), China SXT Pharmaceuticals's total revenue was $1.20M, an increase of 162.99% from the same quarter last year. In Q4, China SXT Pharmaceuticals's net income was $163.72K. See China SXT Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
$ 1.07M$ 1.74M$ 1.93M$ 1.97M$ 2.60M
Gross Profit
$ 183.28K$ 367.43K$ 553.97K$ 426.27K$ 1.25M
Operating Expenses
$ 7.31M$ 3.05M$ 3.07M$ 6.03M$ 6.44M
Depreciation and Amortization
$ 143.22K$ 82.30K$ 203.25K$ 250.16K$ 320.01K
EBITDA
$ -6.98M$ -2.57M$ -2.35M$ -5.21M$ -5.05M
Operating Income
$ -7.12M$ -2.68M$ -2.52M$ -5.61M$ -5.19M
Other Income/Expenses
$ 1.05M$ -623.17K$ -583.32K$ -327.26K$ -218.28K
Pretax Income
$ -6.07M$ -3.30M$ -3.10M$ -5.93M$ -5.41M
Net Income
$ -6.21M$ -3.30M$ -3.10M$ -5.93M$ -5.74M
Per Share Metrics
Basic EPS
$ -9.13$ -8.18$ -3.57$ -22.23$ -137.92
Diluted EPS
$ -9.13$ -8.18$ -3.57$ -22.23$ -137.92
Weighted Average Shares Outstanding
 679.65K 403.92K 867.42K 266.97K 41.59K
Weighted Average Shares Outstanding (Diluted)
 679.65K 403.92K 867.42K 266.97K 41.59K
Currency in USD

China SXT Pharmaceuticals Earnings and Revenue History